This trial will focus on three groups of brain tumor patients aged 4-18 to see if cognitive function can be predicted using imaging and cognitive testing.
5 Primary · 0 Secondary · Reporting Duration: Up to 27 months
Experimental Treatment
200 Total Participants · 3 Treatment Groups
Primary Treatment: Neurocognitive testing · No Placebo Group · N/A
Age 4 - 18 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: